Pfizer -Walk-In Drive For Multiple Openings in Manufacturing Function On 18th Feb’ 2023
Pharma Pathway
FEBRUARY 14, 2023
Candidates from OSD and Injectibels can attend interview.
83 
Pfizer -Walk-In Drive For Multiple Openings in Manufacturing Function On 19th Feb’ 2023
Pharma Pathway
FEBRUARY 14, 2023
Candidates from OSD and Injectibels can attend interview.
FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction
Pharmaceutical Business Review
MARCH 11, 2024
This label expansion follows a supplemental New Drug Application (sNDA) submitted by the company. Additionally, the updated label for Wegovy includes findings demonstrating a 15% decline in cardiovascular mortality and a 19% reduction in mortality from any cause, both versus placebo.
Let's personalize your content